Teva, amid massive restructuring, closes in on $3B cost-cutting goal | Fierce Pharma
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva Stock Falls Because 2019 Will Be a 'Trough Year' | Barron's
Teva to settle opioid-related claims in Florida for $117 million | The Times of Israel
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceutical Reports a Step Back in 2019 | The Motley Fool
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva Stock: Sales Miss As Obstacles Continue To Mount | Investor's Business Daily
Teva's Latest Deal Looks a Healthier Mouthful -- Heard on the Street - WSJ
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions